Intracochlear fibrosis following cochlear implantation: biomechanical mechanisms, effects, and treatments
Active Grant Awarded
- Award ID
- RDC023603UJKN51
- Recipient
-
Oregon Health & Science University UEI NPSNT86JKN51
- Awarding agency
-
National Institute on Deafness and Other Communincation Disorders
National Institutes of Health, Department of Health and Human Services
- Obligated
- $629,799
Award facts
- Assistance listing
- 93.DC1 Research Related to Deafness and Communication Disorders - Research Project Grants (RPGs)
- Completion date 1% complete
- Place of performance
- Portland, OR 97239, USA
Award details come from USAspending.gov.
About this award
The National Institute on Deafness and Other Communication Disorders, part of the Department of Health and Human Services' National Institutes of Health, awarded Oregon Health & Science University $629,799 obligated on Nov 6, 2026, under Research Related to Deafness and Communication Disorders - Research Project Grants (RPGs), CFDA 93.DC1, as Grant RDC023603UJKN51. The recipient will study intracochlear fibrosis after cochlear implantation, investigating the biomechanics and biochemistry of residual hearing loss after cochlear implant (CI) placement to improve long-term residual hearing preservation. The project tests three hypotheses: that CI-induced fibrosis causes the decline in speech perception after implantation, that this decline results from fibrosis interfering with basic cochlear mechanical function, and that vibration of the CI stimulates fibrosis formation. Methods build on infrared optical imaging of vibration in the implanted rodent cochlea and signal processing algorithms applied to speech-like signals, and the work examines how hearing organ mechanics interact with the implant and the fibrosis. The period of performance runs from the Nov 6, 2026 award date to ultimate completion on Nov 30, 2031. Place of performance is Portland, OR 97239, USA.
Description
- Abstract
- Cochlear implants (CIS) are a prosthesis success story. Residual hearing preservation allows for electroacoustic stimulation (EAS) of the cochlea which improves perception of speech in noise, as well as music and intonation, over a CI alone. However, up to 50% of patients lose >30 DB of their residual hearing gradually following CI. Improving long-term preservation of residual hearing is critical to extend these benefits to more CI recipients, and make CIS more biocompatible overall, to allow more people to receive a CI. In this proposal, we will investigate the mechanics and biochemistry of residual hearing loss after CI, using what we find to address our long-term goal of improving CI outcomes for patients. We will investigate the mechanical deficit caused by the fibrosis response to the CI. We are the first research group to use infrared optical imaging to make vibration measurements of the implanted rodent cochlea. We also used innovative signal processing algorithms to uncover that speech-like signals elicit unexpected, large and extremely low frequency mechanical responses in the cochlea, that have never been seen before, and that should be below the low frequency limit of hearing. We will use these techniques and what we have learned about the mechanics of speech processing to test the hypotheses that 1) CI-caused fibrosis is the reason that speech perception declines after receiving a CI and 2) that decline is due to interference with the basic mechanical function of the cochlea by the fibrosis. Crucially, we found that mechanically activated signal transduction pathways are upregulated during the formation of CI-induced fibrosis. Therefore, we will investigate how the mechanics of the hearing organ interact directly with the implant and the fibrosis. We hypothesize that 3) vibration of the CI stimulates fibrosis formation. We also hypothesize that 4) therapeutically targeting these signal transduction pathways with highly specific drugs has the potential to suppress fibrosis formation and thus improve hearing outcomes for all future CI recipients.
Quick answers
Who received award RDC023603UJKN51?
RDC023603UJKN51 was awarded to Oregon Health & Science University by National Institute on Deafness and Other Communincation Disorders (National Institutes of Health) on November 6, 2026.
How much is award RDC023603UJKN51 worth?
$629,799 has been obligated on RDC023603UJKN51.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award